Project Code: SCF-AMC-NFCAG-0001
Disease Domain: Huntington’s Disease, Polyglutamine Disorders, Prion-Like Proteinopathies, Neurodevelopmental Trauma Biology
PHASE 0 — DISEASE INTELLIGENCE & POSITIONING
Objective
Establish the complete scientific, clinical, molecular, and translational foundation of the disease program.
Mandatory Deliverables
0.1 Disease Intelligence Report
- Epidemiology
- Natural history
- Disease burden
- Clinical spectrum
- Mortality analysis
- Economic burden
0.2 Disease Classification Dossier
- ICD classification
- OMIM mapping
- Orphan disease status
- Neurodegenerative classification
- Proteinopathy classification
- SCF disease classification
0.3 Huntington Disease Positioning Document
- Comparison with Alzheimer’s
- Comparison with Parkinson’s
- Comparison with ALS
- Comparison with Prion diseases
- Comparison with Spinocerebellar Ataxias
0.4 PolyQ Disease Comparative Atlas
- HTT
- ATXN1
- ATXN2
- ATXN3
- ATN1
- TBP
- AR
0.5 Knowledge Gap Assessment
- Existing unknowns
- Biomarker gaps
- Therapeutic gaps
- Mechanistic gaps
0.6 Disease Origin Intelligence Map
0.7 SCF Research Charter
0.8 Regulatory Landscape Assessment
0.9 Existing Therapeutic Pipeline Review
0.10 Advanced Literature Intelligence Database
PHASE 1 — DISEASE ORIGIN DISCOVERY
Objective
Determine all causal and contributory origins.
Mandatory Deliverables
1.1 Etiopathogenic Core Report
1.2 HTT Mutation Origin Analysis
1.3 Germline vs Somatic Expansion Atlas
1.4 DNA Repair Modifier Gene Atlas
Genes:
- MSH3
- FAN1
- PMS1
- PMS2
- MLH1
- MSH2
- EXO1
- LIG1
- PCNA
1.5 Developmental Vulnerability Report
1.6 Prenatal Programming Report
1.7 Maternal Trauma-Epigenomic Assessment
1.8 Neurodevelopmental Risk Matrix
1.9 SCF Disease-Origin Model
1.10 Origin Convergence Blueprint
PHASE 2 — SCF FAULT ARCHITECTURE
Objective
Map all biological failures.
Mandatory Deliverables
2.1 SCF Fault Architecture Master Map
2.2 Molecular Fault Atlas
2.3 DNA Repair Failure Atlas
2.4 Protein Misfolding Architecture
2.5 Aggregate Propagation Model
2.6 Cellular Failure Map
2.7 Neuroimmune Failure Map
2.8 Connectomic Failure Atlas
2.9 Behavioral Fault Matrix
2.10 Systemic Failure Matrix
2.11 Multi-Tier Disease Cascade Model
PHASE 3 — MULTI-OMICS RECONSTRUCTION
Objective
Reconstruct disease from genomic through behavioral layers.
Mandatory Deliverables
Genomics Deliverables
3.1 HTT Genomic Atlas
3.2 Whole Genome Variant Map
3.3 DNA Repair Modifier Network
3.4 PolyQ Expansion Atlas
Transcriptomics Deliverables
3.5 RNA-Seq Expression Atlas
3.6 Alternative Splicing Atlas
3.7 Non-Coding RNA Atlas
3.8 MicroRNA Regulatory Map
Epigenomics Deliverables
3.9 DNA Methylation Atlas
3.10 Histone Modification Atlas
3.11 Chromatin Accessibility Map
3.12 Trauma-Epigenomic Signature Atlas
Proteomics Deliverables
3.13 Mutant Huntingtin Proteome
3.14 Aggregate Burden Atlas
3.15 Chaperone Network Map
3.16 Proteostasis Failure Atlas
Metabolomics Deliverables
3.17 Energy Failure Atlas
3.18 Mitochondrial Dysfunction Map
3.19 Oxidative Stress Atlas
Connectomics Deliverables
3.20 Cortico-Striatal Network Atlas
3.21 Neurofunctional Connectivity Map
3.22 Cognitive Circuit Reconstruction
Integrated Deliverables
3.23 Multi-Omics Convergence Atlas
3.24 SCF Reverse-Omics Blueprint
PHASE 4 — PATHOGENESIS & PROGRESSION MODEL
Objective
Model disease progression over time.
Mandatory Deliverables
4.1 Molecular Pathogenesis Map
4.2 Disease Progression Cascade
4.3 Temporal Expansion Model
4.4 Protein Misfolding Progression Model
4.5 Aggregate Spread Model
4.6 Neuronal Vulnerability Atlas
4.7 Clinical Stage Transition Model
4.8 Symptom Evolution Atlas
4.9 Progression Prediction Engine
4.10 SCF Disease Progression Blueprint
PHASE 5 — MATERNAL TRAUMA, PRECONCEPTION & PREGNANCY MODEL
Objective
Map developmental programming influences.
Mandatory Deliverables
5.1 Maternal Trauma-Epigenomic Dossier
5.2 Prenatal Neurodevelopment Atlas
5.3 Placental Biology Report
5.4 Fetal Stress Programming Model
5.5 Neuroimmune Priming Atlas
5.6 Mitochondrial Inheritance Assessment
5.7 Developmental Resilience Matrix
5.8 Behavioral Vulnerability Framework
5.9 Neurodevelopmental Trajectory Model
5.10 SCF Prenatal Systems Blueprint
PHASE 6 — DISEASE MODELING & SIMULATION
Objective
Create quantitative disease intelligence metrics.
Mandatory Deliverables
6.1 CAG Repeat Burden Score Framework
6.2 Somatic Expansion Index
6.3 Protein Misfolding Load Score
6.4 Aggregate Toxicity Score
6.5 DNA Repair Instability Index
6.6 Neurodevelopmental Resilience Index
6.7 Trauma-Epigenomic Load Index
6.8 Cognitive Regulation Score
6.9 Executive Function Score
6.10 Behavioral Stability Score
6.11 Neuroimmune Burden Index
6.12 Neurodegenerative Risk Score
6.13 SCF Neurofunctional Capacity Index
6.14 Integrated Disease Simulation Engine
6.15 Progression Forecasting Platform
PHASE 7 — BIOMARKER DISCOVERY
Objective
Identify diagnostic and predictive biomarkers.
Mandatory Deliverables
7.1 Genetic Biomarker Atlas
7.2 Somatic Expansion Biomarker Atlas
7.3 DNA Repair Biomarker Panel
7.4 Proteomic Biomarker Panel
7.5 Neurodegeneration Biomarker Panel
7.6 Neuroimmune Biomarker Panel
7.7 Epigenomic Biomarker Panel
7.8 Imaging Biomarker Atlas
7.9 Connectomic Biomarker Atlas
7.10 Cognitive Biomarker Framework
7.11 Behavioral Biomarker Framework
7.12 Composite Disease Activity Score
7.13 Composite Progression Score
7.14 Clinical Decision Biomarker Platform
PHASE 8 — THERAPEUTIC VULNERABILITY DISCOVERY
Objective
Identify intervention opportunities.
Mandatory Deliverables
8.1 Therapeutic Vulnerability Atlas
8.2 HTT-Lowering Opportunity Assessment
8.3 DNA Repair Modulation Blueprint
8.4 Somatic Expansion Suppression Blueprint
8.5 Proteostasis Restoration Blueprint
8.6 Autophagy Enhancement Strategy
8.7 Neuroimmune Modulation Blueprint
8.8 Mitochondrial Stabilization Blueprint
8.9 Trauma-Loop Intervention Framework
8.10 Neuroplasticity Enhancement Blueprint
8.11 Combination Therapy Matrix
8.12 SCF Therapeutic Prioritization Engine
PHASE 9 — ADVANCED MEDICINE TRANSLATION
Objective
Translate discoveries into clinical development.
Mandatory Deliverables
9.1 Preventative Strategy Blueprint
9.2 Curative Strategy Blueprint
9.3 Restorative Strategy Blueprint
9.4 SCF-PCR Therapeutic Architecture
9.5 Patient Stratification Framework
9.6 Precision Medicine Classification System
9.7 Clinical Trial Biomarker Package
9.8 IND-Enabling Research Package
9.9 FDA Translational Roadmap
9.10 Clinical Development Plan
9.11 SCF Therapeutic Ecosystem Blueprint
PHASE 10 — MASTER DISEASE INTELLIGENCE SYNTHESIS
Objective
Integrate all knowledge into a complete disease intelligence system.
Mandatory Deliverables
10.1 SCF Encyclopedia Entry
10.2 Master Disease Intelligence Dossier
10.3 HTT CAG Expansion Atlas
10.4 DNA Repair Atlas
10.5 PolyQ Proteinopathy Atlas
10.6 Neurodevelopmental Intelligence Report
10.7 Trauma-Epigenomic Master Report
10.8 Disease Progression Intelligence Model
10.9 Symptom Flare Prediction Engine
10.10 Therapeutic Opportunity Blueprint
10.11 SCF Clinical Deployment Package
10.12 SCF Research Data Repository
10.13 SCF AI Knowledge Graph
10.14 Disease Digital Twin Framework
10.15 Master Translational Medicine Blueprint
PROGRAM-LEVEL FINAL DELIVERABLES
Executive Deliverables
- Master Scientific Dossier
- Master Clinical Dossier
- Master Biomarker Dossier
- Master Therapeutic Dossier
- Master Translational Dossier
- Regulatory Readiness Package
- FDA IND Strategy Package
- Precision Medicine Deployment Package
- SCF Disease Digital Twin Platform
- SCF Neurofunctional Capacity Framework
Advanced Intelligence Deliverables
- HTT–DNA Repair Systems Atlas
- PolyQ Pathogenesis Encyclopedia
- Neurodevelopmental Vulnerability Atlas
- Trauma-Epigenomic Intelligence Atlas
- Connectomic Disease Atlas
- Neuroimmune Convergence Atlas
- Disease Progression Forecasting Platform
- Therapeutic Prioritization Engine
- Clinical Decision Support Framework
- SCF Integrated Knowledge Graph
MASTER REGISTRY INDEX
SCF-AMC-NFCAG-0001 — PROJECT NEUROFOLD-CAG
SCF-DMRD-MASTER-0001 — SCF Advanced Disease Modeling & Discovery
SCF-PATH-UT-0001 — SCF Pathophysiology Protocol
SCF-CRD-WORKFLOW-0001 — SCF Clinical Research & Development Workflow
SCF-ENC-CAG-0001 — CAG Repeat Expansion Disorders
SCF-ENC-PRG-0001 — Prionogenesis Encyclopedia
SCF-SEF-MD-0001 — SCF Synergistic Evaluation Framework
SCF-AMC-NEURO-ATLAS-0001 — Neurodegenerative Disease Atlas Program
SCF-AMC-DIGITALTWIN-0001 — Disease Digital Twin Platform
SCF-AMC-TRANSLATE-0001 — Advanced Medicine Translational Framework